Disease managementBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7234.588/a (Published 26 February 2000) Cite this as: BMJ 2000;320:588
- Douglas Carnall (email@example.com)
Those of us who look on in bewilderment at the US ability to commercialise anything will find such brash commercial solutions for human suffering as disease management distasteful. This week's BMJ carries a critique of the US “health” marketplace, in which “disease management” is the next big thing.
In any such development there will be good and bad, and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial